Botanical species · safety record

Spigelia anthelmia

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Spigelia anthelmia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Spigelia anthelmia L.

7Constituent measurements

1Safety records

3Cited sources

79Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 79 licensed products naming Spigelia anthelmia as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Aerial parts of the plant
Dried aerial part(s)
Dried aerial parts
Plante entière
Root
Spigelia anthelmia L., dried aerial parts
Tincture of the whole plant
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Ryanodine	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR) and Electron Spin Resonance (ESR) spectroscopy	Resolve DOI
Spiganthine	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR) and Electron Spin Resonance (ESR) spectroscopy	Resolve DOI
Alkaloids	Aerial part of plants	Solvent extraction	0.84 Percent	Phytochemical screening	No resolvable identifier
Cardiac glycosides	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Phlobotannins	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Saponins	Aerial part of plants	Solvent extraction	2.26 Percent	Phytochemical screening	No resolvable identifier
Tannins	Aerial part of plants	Solvent extraction	15.05 Percent	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Pulmonary and cardiac	Respiratory	Aerial part of plants	Solvent extraction	House mouse (as animal)	Acute toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Edeoga, HO., Okwu, DE., Mbaebie, BO. Phytochemical constituents of some Nigerian medicinal plants. AFRICAN JOURNAL OF BIOTECHNOLOGY, 2005, vol. 4, no. 7, p. 685-688.
Camurca-Vasconcelos, ALF., Nascimento, NRF., Sousa, CM., Melo, LM., Morais, SM., Bevilaqua, CML., Rocha, MFG. Neuromuscular effects and acute toxicity of an ethyl acetate extract of Spigelia anthelmia Linn. . Journal of ethnopharmacology, 2004, vol. 92, no. 2-3, p. 257-261.
ACHENBACH, H., HUBNER, H., VIERLING, W., BRANDT, W., REITER, M. CONSTITUENTS OF TROPICAL MEDICINAL-PLANTS .68. SPIGANTHINE, THE CARDIOACTIVE PRINCIPLE OF SPIGELIA-ANTHELMIA . Journal of natural products-lloydia, 1995, vol. 58, no. 7, p. 1092-1096. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature